Nathavy UM DIN

Mrs. Nathavy UM DIN

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2022 in Gerontology
Verified
Journal Article
Closed access
PDF file
NLNolwenn Lapierre
Nolwenn Lapierre
NDNathavy UM DIN
Nathavy UM DIN
Joel BelminJoel Belmin
Joel Belmin
CLCarmelo Lafuente-Lafuente
Carmelo Lafuente-Lafuente
Introduction: Exergaming is increasingly employed in rehabilitation for older adults. However, their effects on fall rate and fall risk remain unclear. Methods: We conducted a systematic review and meta-analysis that included randomized controlled trials (RCTs) comparing exergame-assisted rehabilitation with control groups, published in French or English, from Web of Science, CINHAL, Embase, Medline, and CENTRAL (last search in June 2021). Two reviewers independently assessed the studies. Risk of bias was assessed using RoB2, PEDRO scale, and the GRADE system. The outcomes of interest were (a) fall rate, (b) risk of falling, measured by the Short Physical Performance Battery (SPPB), Timed Up and Go (TUG), One-Leg Stance, or Berg Balance Scale (BBS), (c) fear of falling, measured with the Fall Efficacy Scale (FES-I) or the Activities-specific Balance Confidence (ABC) score. Data were pooled and mean differences (MDs) between exergame and control groups were calculated using a random-effects model. Results: Twenty-seven RCTs were included (1,415 participants, including 63.9% of women, with mean age ranging from 65 to 85.2 years old). Exergame-assisted interventions were associated with a reduction in the incidence of falls (4 studies, 316 participants, MD = −0.91 falls per person per year; 95% CI: −1.65 to −0.17, p = 0.02, moderate quality). Regarding fall risk (20 studies included, low-quality evidence), SPPB did not change (MD = 0.74; 95% CI: −0.12 to 1.60, p = 0.09), but all other scores were improved: BBS (MD = 2.85; 95% CI: 1.27 to −4.43, p = 0.0004), TUG (MD = −1.46; 95% CI: −2.21 to −0.71, p = 0.0001) and One-Leg Stance (MD = 7.09; 95% CI: 4.21 to 9.98, p < 0.00001). Fear of falling scores (FES-I and ABC) showed no difference. Conclusion: There is moderate-quality evidence of a reduction in the fall rate with exergame-assisted rehabilitation and low-quality evidence suggesting a mild reduction in the risk of falling. Statistically significant benefits from exergame-assisted rehabilitation did not achieve clinically meaningful changes in risk of falling assessments.

2 August 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
VZVictoria Zolnowski-Kolp
Victoria Zolnowski-Kolp
NDNathavy UM DIN
Nathavy UM DIN
CHCharlotte Havreng-Théry
Charlotte Havreng-Théry
SPSylvie Pariel
Sylvie Pariel
JVJacques-Henri Veyron
Jacques-Henri Veyron
Joel BelminJoel Belmin
Joel Belmin
Background: Frailty assessment is a major issue in geriatric medicine. The Vulnerable Elders Survey-13 (VES-13) is a simple and practical tool that identifies frailty through a 13-item questionnaire completed by older adults or their family caregivers by self-administration (pencil and paper) or by telephone interview. The VES-13 provides a 10-point score that is also a recognized mortality predictor. Objective: This study aims to design an electronic version of the Echelle de Vulnérabilité des Ainés-13, the French version of the VES-13 (eEVA-13) for use on a digital tablet and validate it. Methods: The scale was implemented as a web App in 3 different screens and used on an Android tablet (14.0× 25.6 cm). Participants were patients attending the outpatient clinic of a French geriatric hospital or hospitalized in a rehabilitation ward and family caregivers of geriatric patients. They completed the scale twice, once by a reference method (self-administered questionnaire or telephone interview) and once by eEVA-13 using the digital tablet. Agreement for diagnosis of frailty was assessed with the κ coefficient, and scores were compared by Bland and Altman plots and interclass correlation coefficients. User experience was assessed by a self-administered questionnaire. Results: In total, 86 participants, including 40 patients and 46 family caregivers, participated in the study. All family caregivers had previously used digital devices, while 13 (32.5%) and 10 (25%) patients had no or infrequent use of them previously. We observed no failure to complete the eEVA-13, and 70% of patients (28/40) and no family caregivers needed support to complete the eEVA-13. The agreement between the eEVA-13 and the reference method for the diagnosis of frailty was excellent (κ=0.92) with agreement in 83 cases and disagreement in 3 cases. The mean difference between the scores provided by the 2 scales was 0.081 (95% CI–1.263 to 1.426). Bland and Altman plots showed a high level of agreement between the eEVA-13 and the reference methods and interclass correlation coefficient value was 0.997 (95% CI 0.994-0.998) for the paper and tablet group and 0.977 (95% CI 0.957-0.988) for the phone and tablet groups. The tablet assessment was found to be easy to use by 77.5% (31/40) of patients and by 96% (44/46) of caregivers. Finally, 85% (39/46) of family caregivers and 50% (20/40) of patients preferred the eEVA-13 to the original version. Conclusions: The eEVA-13 is an appropriate digital tool for diagnosing frailty and can be used by older adults and their family caregivers. The scores obtained with eEVA-13 are highly correlated with those obtained with the original version. The use of health questionnaires on digital tablets is feasible in frail and very old patients, although some patients may need help to use them.

22 August 2024
Verified
Book Chapter
Open access
PDF file
NDNathavy UM DIN
Nathavy UM DIN
FMFlorian Maronnat
Florian Maronnat
SPSylvie Pariel
Sylvie Pariel
FBFadi Badra
Fadi Badra
Joel BelminJoel Belmin
Joel Belmin
The diagnosis of neurocognitive diseases is an important health issue for patients, families and healthcare professionals. The need to develop rapid, high-performance screening tools would improve access to care. The Clock Drawing Test (CDT) is widely used and validated with the older adults, and its digital version is becoming increasingly widespread. We propose to confirm its validity in a population of old patients hospitalized in a geriatric unit, and secondly to verify its performance in comparison with the reference diagnosis made by a specialized team in a memory consultation. CDTs were collected from older hospitalized patients, both in paper form and digitally on a touchscreen tablet. The results show good agreement between the paper and digital versions (kappa coefficient = 0.81). Sensitivity and specificity of the digital CDT were 0.84 and 0.59 respectively for the diagnosis of major cognitive disorders. The corresponding values were 0.72 and 0.59 for the diagnosis of mild neurocognitive disorders. User questionnaires indicate that older participants find the digital tablet easy to use. However, they prefer to use paper, even if they are open to learning how to use the tablet.

1 July 2025 in Age and Ageing
Verified
Journal Article
Open access
NDNathavy UM DIN
Nathavy UM DIN
FMFlorian Maronnat
Florian Maronnat
VZVictoria Zolnowski-Kolp
Victoria Zolnowski-Kolp
SOSamir Otmane
Samir Otmane
Joel BelminJoel Belmin
Joel Belmin
Facing an increasing prevalence, diagnosis and management of dementia has become a global health challenge. While most cognitive assessments are based on paper tests, the current trend is to digitise them, using new technologies. We aimed to achieve a systematic review on touchscreen-based assessments for neurocognitive disorders. A search on four databases (PubMed, Embase, IEEE Xplore and Web of Science) was performed. Two investigators independently selected the articles and assessed their quality using the QUADAS-2 tool. We included articles whose participants were over 65 years, classified according to the presence/absence of major neurocognitive disorder (M-NCD) determined by conventional assessment of cognition, examined with a novel tool using a touchscreen device (tablet or smartphone). We finally retained 35 articles for the systematic review and 24 for the meta-analysis. Of the 35 articles included in the systematic review, participants had Alzheimer’s disease, Parkinson’s disease, vascular dementia, Lewy body disease or any type of dementia. Pooled sensitivity and specificity were 0.89 (95% CI: 0.86–0.91) and 0.88 (95% CI: 0.82–0.92), respectively. Performances of self-administered or brief assessment testings were similar to those of assessor-administered or longer duration testings. The major limitation of this review and meta-analysis is the multiplicity and diversity of methods (tools, cognition assessment and type of M-NCD), which make the comparison difficult. We conclude that brief and self-assessment touchscreen-based cognitive tests are appropriate and simple tools to screen major cognitive disorders that can be used in primary care. The study was registered in Prospero (CRD42022358725).

26 August 2021 in JMIR Research Protocols
Verified
Journal Article
Open access
NLNolwenn Lapierre
Nolwenn Lapierre
NDNathavy UM DIN
Nathavy UM DIN
MIManuella Igout
Manuella Igout
JCJoël Chevrier
Joël Chevrier
Joel BelminJoel Belmin
Joel Belmin
Background: Older adults often experience physical, sensory, and cognitive decline. Therefore, they have a high risk of falls, which leads to severe health and psychological consequences and can induce fear of falling. Rehabilitation programs using exergames to prevent falls are being increasingly studied. Medimoov is a movement-based patient-personalized exergame for rehabilitation in older adults. A preliminary study showed that its use may influence functional ability and motivation. Most existing studies that evaluate the use of exergames do not involve an appropriate control group and do not focus on patient-personalized exergames. Objective: This study aims to evaluate the effects of Medimoov on risk of falls and fear of falling in older adults compared with standard psychomotor rehabilitation. Methods: This is a serial, comparative, randomized controlled group study. Both groups (n=25 in each) will receive psychomotor rehabilitation care. However, the methods of delivery will be different; one group will be exposed to the Medimoov exergame platform, and the other only to traditional means of psychomotor rehabilitation. The selection criteria will be (1) age of 65 years or older, (2) ability to answer a questionnaire, (3) ability to stand in a bipedal position for at least 1 minute, (4) score of 13 or greater on the Short Fall Efficacy Scale, and (5) stable medical condition. An evaluation will be made prior to starting the intervention, after 4 weeks of intervention, and at the end of the intervention (after 8 weeks), and it will focus on (1) risk of falls, (2) fear of falling, and (3) cognitive evaluations. Physical activity outside the session will also be assessed by actimetry. The outcome assessment will be performed according to intention-to-treat analysis. Results: The protocol (2019-11-22) has been approved by the Comité de Protection des Personnes Nord-Ouest I–Université de Rouen (2019-A00395-52), which is part of the French national ethical committee. The study received funding in February 2020. As of October 2020 (submission date), and due to the context of the COVID-19 pandemic, a total of 10 participants out of 50 had been enrolled in the study. The projected date for the end of the data collection is December 2021. Data analyses have not been started yet, and publication of the results is expected for Spring 2022. Conclusions: The effects of psychomotor rehabilitation using the Medimoov exergame platform on the risk and fear of falls will be evaluated. This pilot study will be the basis for larger trials. Trial Registration: ClinicalTrials.gov NCT04134988; https://clinicaltrials.gov/ct2/show/NCT04134988 International Registered Report Identifier (IRRID): DERR1-10.2196/24665

22 August 2024
Verified
Book Chapter
Open access
PDF file
NDNathavy UM DIN
Nathavy UM DIN
FMFlorian Maronnat
Florian Maronnat
QBQuentin Le Boterff
Quentin Le Boterff
SOSamir Otmane
Samir Otmane
FBFadi Badra
Fadi Badra
Joel BelminJoel Belmin
Joel Belmin
Neurocognitive diseases are diagnosed in specialized centers such as memory clinics, where the waiting time can be long. The reference assessment involves a battery of tests carried out by a specialized team. Facilitating screening in primary care using new technologies could make it possible to appropriately direct care pathways towards specialist care. This work aimed to set up a battery of questionnaires, cognitive and manual dexterity tests on a digital tablet to screen people with cognitive impairment. Three groups of people are recruited from a memory consultation: people with major neurocognitive disorders, people with mild neurocognitive disorders and people with no cognitive impairment. Initial results in geriatric settings show that the digital tablet assessment test is feasible and well accepted, but that manual dexterity assessment needs to be adapted to the bodily particularities of the very old.